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Abstract Several EF-hand recoverin mutants were obtained and
their abilities to bind to photoreceptor membranes and to inhibit
rhodopsin kinase were determined. The mutants with the ‘spoiled’
2nd, 3rd or (2nd+3rd) EF-hand structures did not act upon the
kinase activity in the WM range of Ca2+ concentrations.
Mutations of the 4th EF hand, which ‘repaired’ its Ca2+-binding
activity, resulted in recoverin with three ‘working’ Ca2+-binding
sites. The latter mutant inhibited rhodopsin kinase even more
effectively than the wild-type recoverin, containing two working
Ca2+-binding structures.
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1. Introduction
Recoverin (the initial name ‘p26’ [1]) is a protein from bo-
vine retinal rod cells [1^3] which belongs to the EF-hand
superfamily of Ca2-binding proteins. The actual in vivo func-
tion of recoverin continues to be a subject of discussion (see
[4] for review), though according to a number of in vitro data
obtained in rod outer segment (ROS) suspensions and recon-
stituted systems [5^9] it inhibited rhodopsin kinase in a Ca2-
dependent manner that pointed at the kinase as a cell target of
recoverin. Amino terminus of recoverin is heterogeneously
fatty acylated (mainly myristoylated) [10] and this modi¢ca-
tion enhances the recoverin inhibitory e⁄ciency with respect
to rhodopsin kinase and confers cooperativity with respect to
Ca2 on this inhibitory e¡ect [11]. One more important fea-
ture of the recoverin structure is that its molecule is composed
of two domains, each having two potential Ca2-binding sites
of the EF-hand type; of four EF-hand sites, only two (the 2nd
and the 3rd) EF-hands are capable of binding Ca2 whereas
the remaining two sites (the 1st and the 4th ones) do not have
such an ability [12,13]. Since up to now the contribution of
the speci¢c EF-hand structures to the inhibitory activity of
recoverin with respect to rhodopsin kinase is fully unknown,
we obtained several EF-hand recoverin mutants and deter-
mined their ability of binding to photoreceptor membranes
and of inhibiting rhodopsin phosphorylation catalyzed by
rhodopsin kinase Fig. 1.
A preliminary form of this work was presented at the 5th
European Symposium on Calcium Binding Proteins in Nor-
mal and Transformed Cells held in Muºnster, 1998 [14].
2. Materials and methods
[Q-32ATP] was purchased from the Physicoenergetical Institute
(Russia), all the other chemicals were obtained from Sigma and Amer-
sham.
Rod outer segments (ROS) prepared from frozen bovine retinae
under dim red light [15] were frozen in liquid nitrogen and stored at
370‡C. Rhodopsin concentration was determined by the di¡erence in
optical densities of the samples at 500 nm before and after illumina-
tion in the presence of cetyltrimethyl ammonium bromide taking
O= 42 000 [16]. Recoverin concentrations were estimated by absorb-
ance at 280 nm taking O= 36 400 [17]. SDS-PAGE was performed as
described in [18]. Free Ca2 concentrations ([Ca2]f ) in the CaCl2-
EGTA bu¡er were calculated according to [19] and determined using
a Ca2-sensitive electrode [20].
Site-directed mutagenesis was carried out as described in [21]. The
oligonucleotides presented in Table 1 were used as antisense primers
during the obtaining of site-directed mutants. Full length bovine
cDNA [22] was inserted into M13mp19 plasmid (Biolabs) between
the HincII and BamHI sites. Sculptor in vivo mutagenesis system
(Amersham) was used to obtain 3EF2, 3EF3 and 3EF2,3; +EF4
was obtained using megaprimer PCR strategy [23]. The NcoI-HincII
fragments of the mutants were cloned into the NcoI-BamHI digested
pE11d plasmid (Biolabs).
Expression of recombinant forms of recoverin was performed in the
presence of 1 mM isopropyl-L-D-thiogalactopyranoside as described
earlier [11]. Brie£y, the expression vectors, pET11-rec and its mutants
were transfected to E. coli BL21DE3 (Biolabs) with or without
pBB131, an expression vector of N-myristoyl transferase. 3EF2,
3EF3 and +EF4 were puri¢ed according to [11]; in the case of
3EF2,3 gel ¢ltration of Superone 12 (Pharmacia) was used instead
of chromatography on phenyl-Sepharose.
Ca2-dependent binding of recoverin to ROS membranes was de-
termined according to [24] ; the procedure is brie£y described in the
legend to Fig. 2. Rhodopsin phosphorylation was assayed as de-
scribed in [25] at 25‡C in the reaction mixture (50 ml) containing 20
mM Tris-HCl (pH 7.4), 140 mM NaCl, 2 mM MgCl2, 1 mM [Q-
32ATP] (2^5U104 cpm/nmol), 100 WM GTP, 10 WM fully bleached
rhodopsin in the content of ROS membranes, 0.02 E rhodopsin kin-
ase, 15 WM wild-type recombinant myristoylated recoverin (WT-re-
coverin) or its mutants, and Ca2 in the content of the CaCl2-
EGTA bu¡er (as indicated). The reaction was initiated by a light £ash
and the addition of ATP 30 s after the £ash. After 30 min aliquots
were taken from the reaction mixture and mixed with the SDS-PAGE
sample bu¡er to stop the reaction. After SDS-PAGE of the samples,
zones of rhodopsin were cut out and 32P incorporation was estimated
by Cherenkov counting in plastic tubes; the counting level was 3000^
11 000 cpm per sample from which the ‘dark’ level (80^320 cpm) was
subtracted. The data presented in Fig. 3 are means þ S.D. of duplicate
assays carried out on three occasions.
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3. Results and discussion
EF-hand structural motif consists of two perpendicularly
placed K-helices and an interhelical loop, which together
form a Ca2-binding site in the EF-hand superfamily proteins
(see [26] for review). In the recoverin EF-hand structure six
amino acid residues are involved in the binding of Ca2 ; ¢ve
of them are in the loop and the sixth one, namely glutamate,
is present in the Z-position of the 2nd helix of the helix-loop-
helix motif [13]. Using site-directed mutagenesis, we obtained
four EF-hand mutants of recoverin. In three mutants substi-
tutions of glutamate for glutamine in the Z-position of the
2nd and/or the 3rd EF-hand sites were made to ‘spoil’
Ca2-binding properties of the corresponding sites. The aim
of substitutions in the fourth mutant was to give to its 4th
EF-hand site the canonical EF-hand properties and thus to
confer on this site a Ca2-binding capacity.
The ‘spoiled’ recoverin mutants were the following: (i)
E85Q in the 2nd EF hand (it was symbolized as ‘3EF2’) ;
(ii) E121Q in the 3rd EF hand (‘3EF3’); and (iii) simultane-
ously E85Q in the 2nd and E121Q in the 3rd EF hands
(‘3EF2,3’). The fourth mutant (‘+EF4’) had simultaneously
¢ve substitutions in the 4th EF hand site: G160D, K161E,
K162N, D165G and K166Q that ‘repaired’ it and conferred
on it an ability to bind Ca2. Thus, in contrast to the wild-
type recoverin, containing two ‘natural’ Ca2-binding sites
(the 2nd and 3rd EF-hands), +EF4 had one additional
Ca2-binding site (the 4th EF-hand).
Estimation of the Ca2-binding capacity of the mutants,
using blots probed with 10 mM 45Ca2 [2], revealed that it
was decreased in the order: +EF4vWT-recoverins3EF2
s3EF3s3EF2,3 (data not shown). The latter three mu-
tants were bound weakly to ROS membranes (Fig. 2) and
did not inhibit rhodopsin phosphorylation catalyzed by rho-
dopsin kinase (Fig. 3). In contrast to the mutants with
‘spoiled’ EF hands, the behavior of +EF4 in the experiments
on binding to ROS membranes (see Fig. 2) and on measuring
the inhibitory e⁄ciency (see Fig. 3) was analogous to that of
WT-recoverin in the WM range of Ca2 concentrations. More-
over, this recoverin form containing three working EF-hands
was an even more e¡ective inhibitor of rhodopsin phospho-
rylation; in the presence of +EF4 the plot ‘relative activity of
rhodopsin kinase vs. [Ca2]f ’ was shifted to lower Ca2 con-
centrations in comparison with the same plot but in the pres-
ence of WT-recoverin.
It is yet unclear, whether the ine⁄ciencies mentioned of
3EF2, 3EF3 and 3EF2,3 resulted from the point mutations
as such or from perturbations, caused by the mutations, in the
K-helices and possibly in the overall structure of the recoverin
molecule. To answer this question, an investigation of the
structures of the recoverin mutants is in progress.
Quite recently the obtaining and properties of two EF-hand
mutants of S-modulin (a frog analog of recoverin), similar to
our 3EF2 and 3EF3, were described [27]. These S-modulin
mutants (E85M and E121M), just as E85Q and E121Q of
recoverin, did not inhibit rhodopsin phosphorylation but, in
contrast to our data, E85M, which corresponded to our
3EF2, was able to bind to ROS membranes.
According to our data, the appearance of the 3rd active
Ca2-binding site in the 4th EF hand of +EF4 did not destroy
the recoverin ability to bind to ROS membranes and even
enhanced its inhibitory e⁄ciency with respect to rhodopsin
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Fig. 1. Schematic sketch of EF-hand domains of WT-recoverin and
its EF-hand mutants capable (¢lled boxes) and incapable (empty
boxes) of binding Ca2.
Table 1
Oligonucleotides used in the site-directed mutagenesis of recoverin
Symbols Mutants Oligonucleotide primers
3EF2 E85Q 5P-GCGATGGTACCTTGGACTTCAAGCAGTATGTC-3P
3EF3 E121Q 5P-GCAAGAACCAGGTGCTCGAGTTTGTCACGGAC-3P
3EF2,3 E85Q, E121Q As in 3EF2 and 3EF3 simultaneously
+EF4 G160D, K161E, K162N, D165G, K166Q 5P-GGATTCTTGACGAGAATGATGATGGTCCACTTACAG-3P
The mutation sites are underlined.
Fig. 2. Binding of WT-recoverin and its EF-hand mutants to photo-
receptor membranes in the presence of Ca2. 15-WM recoverin prep-
arations and urea-washed ROS membranes were mixed and incu-
bated at 25‡C for 15 min in 50 mM Tris-HCl (pH 7.5), containing
70 mM NaCl and 175 WM [Ca2]f . Membranes were separated by
centrifugation (275 000Ug, 10 min), extracted with 50 mM Tris-HCl
(pH 7.5), containing 10 mM EGTA and portions of the extracts
were analyzed by SDS-PAGE. Track 1: A total amount of myris-
toylated recoverin of a wild type in the sample analyzed before pre-
incubation in the presence of membranes. Tracks 2^7 demonstrate
an amount of the protein bound to membranes; 2: myristoylated
recoverin of a wild type; 3: non-myristoylated recoverin of a wild
type; 4: 3EF2; 5: 3EF3; 6: 3EF2,3; 7: +EF4.
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kinase. The Hill coe⁄cients, calculated from the plots pre-
sented in Fig. 3, were about 1.6 for WT-recoverin and 1.9
for +EF4, i.e. in the experimental conditions used the ‘arti¢-
cial’ EF-hand site did not show a clearly de¢ned cooperative
interaction with two ‘natural’ Ca2-binding sites of recoverin.
In future it is of interest to compare functional activities of
+EF4 with those of related EF-hand proteins, for example
GCAPs [28,29], molecules which contain 3 Ca2-binding sites.
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Fig. 3. E¡ects of WT-recoverin and its EF-hand mutants upon the
relative rhodopsin kinase (RK) activity at di¡erent [Ca2]f values.
The 32P incorporation in the absence of recoverin is taken as 100%.
15-WM myristoylated recoverin forms were added; WT-recoverin
(O) ; 3EF2 (E) ; 3EF3 (P) ; 3EF2,3 (7) ; +EF4 (F) ; without re-
coverin (a).
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